Kidney cancer involves the abnormal and uncontrolled growth of cells in the kidneys, a pair of organs that removes waste products from the bloodstream and excretes them as urine. About 90% of kidney cancers are renal cell carcinomas originating in the tubules that transport waste materials from the blood to the urine. Rarer kidney cancers include:
Transitional cell carcinoma (originating from the lining of the renal pelvis where the urine goes before the body transports it to the ureter and urinary bladder).
Wilms' tumor (a subtype primarily affecting children).
Renal sarcoma (from blood vessels and connective tissues within the kidney).
When I met my doctor [at City of Hope], he immediately made me feel at ease. I didn’t feel like a victim; I felt like I was going to be victorious.
— Joelle Hood, kidney cancer survivor
According to the American Cancer Society, about 80,000 new cases of kidney cancer will be diagnosed this year. Kidney cancer is more common in men than women and among African Americans and American Indian and Alaska Native populations.
Your kidney cancer is every bit as unique as you are, and that is why treatment at City of Hope focuses on you and your loved ones. Our physicians will personally consult with you about your disease, treatment options and desired outcomes.
City of Hope is a nationally recognized leader in researching and treating urologic cancers.
For more than a decade, U.S. News & World Report has named City of Hope one of the top cancer hospitals in America and a high-performing hospital in urology.
Our Kidney Cancer Program Highlights:
Our team’s ability to treat complex kidney cancers, including patients with advanced cancers and patients with other medical conditions
Our leadership in urologic surgeries, including minimally invasive and robotic operations that reduce discomfort and recovery time
Our surgeons’ experience in kidney-sparing cancer surgeries, preserving urinary function
Genomic and molecular profiling to identify the best possible treatments
A comprehensive portfolio of drugs that can fight cancer better with fewer side effects
Ongoing research and clinical trials of promising new therapies, including immunity-based and stem cell therapies
Follow-up and recovery program focused on restoring urinary function and improving quality of life
We bring together a broad array of expertise from multiple specialties and are unmatched in our rapid “bench-to-bedside” record of translating leading-edge research into real-world treatments. As a founding member of the National Comprehensive Cancer Network, our doctors also help develop and improve evidence-based kidney cancer treatment guidelines for patients throughout the country.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Lennar Foundation Cancer Center; Newport Beach Fashion Island; Duarte - Main Campus
Sumanta Kumar Pal, M.D., is an internationally recognized leader in the area of genitourinary cancers. He is the co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.